Jeffrey W. Henderson

Director

Mr. Henderson brings nearly 30 years of financial, commercial, and pharmaceutical industry expertise to the Board of Directors. He has served as President of JWH Consulting LLC, an investment and business advisory firm, since January 2018.  From 2015 to 2019, he served as a Healthcare Advisory Director to Berkshire Partners LLC.  Mr. Henderson previously served as the Chief Financial Officer of Cardinal Health, Inc., a multinational health care services company, from May 2005 to November 2014, and in an executive capacity until his retirement from Cardinal in August 2015. From 1998 to 2005, Mr. Henderson held various senior management positions at Eli Lilly and Company, a multinational pharmaceutical company, including President and General Manager, Eli Lilly Canada, Inc. and Controller and Treasurer of Eli Lilly, Inc.  He received his BS in electrical engineering from Kettering University, Flint, Mich., and his MBA from Harvard Graduate School of Business Administration. Mr. Henderson serves on the board of directors of Becton Dickinson and Company, Fibrogen, Inc., and Qualcomm, Inc. He serves on the Halozyme Compensation Committee and is the Chair of the Audit Committee.